A natural histone H2A variant lacking the Bub1 phosphorylation site and regulated depletion of centromeric histone CENP-A foster evolvability in Candida albicans.
Cedric A BrimacombeJordan E BurkeJahan-Yar ParsaSandra CataniaTeresa R O'MearaJessica N WitchleyLaura S BurrackHiten D MadhaniSuzanne M NoblePublished in: PLoS biology (2019)
Eukaryotes have evolved elaborate mechanisms to ensure that chromosomes segregate with high fidelity during mitosis and meiosis, and yet specific aneuploidies can be adaptive during environmental stress. Here, we identify a chromatin-based system required for inducible aneuploidy in a human pathogen. Candida albicans utilizes chromosome missegregation to acquire tolerance to antifungal drugs and for nonmeiotic ploidy reduction after mating. We discovered that the ancestor of C. albicans and 2 related pathogens evolved a variant of histone 2A (H2A) that lacks the conserved phosphorylation site for kinetochore-associated Bub1 kinase, a key regulator of chromosome segregation. Using engineered strains, we show that the relative gene dosage of this variant versus canonical H2A controls the fidelity of chromosome segregation and the rate of acquisition of tolerance to antifungal drugs via aneuploidy. Furthermore, whole-genome chromatin precipitation analysis reveals that Centromere Protein A/ Centromeric Histone H3-like Protein (CENP-A/Cse4), a centromeric histone H3 variant that forms the platform of the eukaryotic kinetochore, is depleted from tetraploid-mating products relative to diploid parents and is virtually eliminated from cells exposed to aneuploidy-promoting cues. We conclude that genetically programmed and environmentally induced changes in chromatin can confer the capacity for enhanced evolvability via chromosome missegregation.
Keyphrases
- candida albicans
- transcription factor
- copy number
- biofilm formation
- genome wide
- dna methylation
- gene expression
- dna damage
- protein kinase
- endothelial cells
- induced apoptosis
- genome wide identification
- escherichia coli
- high throughput
- cell cycle arrest
- induced pluripotent stem cells
- cystic fibrosis
- drug induced
- risk assessment
- pluripotent stem cells
- antimicrobial resistance
- climate change
- cell proliferation
- multidrug resistant